MonTa Biosciences ApS: Financial statements 2018
CVR: 36697016
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
MonTa Biosciences ApS (CVR 36697016) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -177,969 and a net result of DKK -759,993 compared with DKK -653,993 the year before. Equity in the 2018 report amounted to DKK 685,927. The solvency ratio was 94.9%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -177,969
- Profit/Loss
- DKK -759,993
- Equity
- DKK 685,927
- Total Assets
- DKK 722,536
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | -178 t. | -760 t. | 686 t. | 1 |
| 2017 | - | -25 t. | -654 t. | 1.4 mio. | 1 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
MonTa Biosciences ApS has published its annual report for 2017. Gross profit came to DKK -24,932, and the net result was DKK -653,993.
About MonTa Biosciences ApS
MonTa Biosciences ApS is a Danish company of the type Anpartsselskab based in Kongens Lyngby, founded in 2015. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named MonTa Biosciences IVS. The management consists of Simon Skjøde Jensen. The board consists of Lone Schøtt Kunøe (chair), Esper Boel, Sven Madsen and Søren Tulstrup. The company's owners include Jonas Rosager Henriksen, TLA-HOLDING 2010 ApS and JENSEN BIOCONSULT ApS. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK 1,811,082 and a net result of DKK -4,776,853 compared with DKK -3,920,572 the year before. Equity in the 2025 report amounted to DKK -10,304,549.